Stockscreener 앱 받기
39.16
1.43%
-0.57
시간 외 거래:
39.16
전일 마감가:
$39.73
열려 있는:
$39.42
하루 거래량:
2.57M
Relative Volume:
0.63
시가총액:
$16.93B
수익:
$2.31B
순이익/손실:
$1.66B
주가수익비율:
17.05
EPS:
2.297
순현금흐름:
$827.02M
1주 성능:
+1.56%
1개월 성능:
+8.78%
6개월 성능:
+21.28%
1년 성능:
+53.09%
1일 변동 폭
$38.82
$39.65
1주일 범위
$38.39
$40.01
52주 변동 폭
$24.05
$41.24
로열티 파마 Stock (RPRX) Company Profile
명칭
Royalty Pharma Plc
전화
(212) 883-0200
주소
110 EAST 59TH STREET, NEW YORK, NY
RPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
39.16 | 16.97B | 2.31B | 1.66B | 827.02M | 2.297 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
로열티 파마 Stock (RPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-30 | 개시 | Goldman | Buy |
| 2025-05-16 | 개시 | Morgan Stanley | Overweight |
| 2024-06-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-06-14 | 재개 | UBS | Buy |
| 2022-05-13 | 개시 | Scotiabank | Sector Outperform |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2021-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-30 | 개시 | Tigress Financial | Buy |
| 2020-11-09 | 업그레이드 | UBS | Neutral → Buy |
| 2020-07-14 | 개시 | Evercore ISI | In-line |
| 2020-07-13 | 개시 | BofA Securities | Buy |
| 2020-07-13 | 개시 | Citigroup | Neutral |
| 2020-07-13 | 개시 | Cowen | Outperform |
| 2020-07-13 | 개시 | Goldman | Neutral |
| 2020-07-13 | 개시 | JP Morgan | Neutral |
| 2020-07-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 개시 | SunTrust | Buy |
| 2020-07-13 | 개시 | UBS | Neutral |
모두보기
로열티 파마 주식(RPRX)의 최신 뉴스
What analysts say about Royalty Pharma plc stockShort-Term Trading Alerts & Easy Tools to Analyze Your Investment Risk - earlytimes.in
Is Royalty Pharma plc (RPD) stock attractive post correctionJuly 2025 PreEarnings & Stepwise Trade Execution Plans - newser.com
What’s the recovery path for long term holders of Royalty Pharma plc - newser.com
Historical volatility pattern of Royalty Pharma plc visualizedSell Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Top chart patterns to watch in Royalty Pharma plcWeekly Investment Report & Verified Momentum Watchlists - newser.com
Analyzing net buyer seller activity in Royalty Pharma plcJuly 2025 Pullbacks & High Accuracy Investment Signals - newser.com
Can Royalty Pharma plc stock rebound after recent weaknessPortfolio Performance Report & High Return Trade Opportunity Guides - newser.com
Royalty Pharma (NASDAQ:RPRX) Upgraded at Wall Street Zen - MarketBeat
Will Royalty Pharma plc (RPD) stock hit Wall Street targetsAnalyst Downgrade & Free High Return Stock Watch Alerts - newser.com
Why Royalty Pharma plc (RPD) stock could outperform next yearMarket Rally & Free Safe Capital Growth Stock Tips - newser.com
Why Royalty Pharma plc (RPD) stock could rally stronglyJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com
Why analysts remain bullish on Royalty Pharma plc stockForecast Cut & AI Forecast Swing Trade Picks - newser.com
Is Royalty Pharma plc stock a safe investment in uncertain marketsWeekly Loss Report & Long-Term Capital Growth Strategies - newser.com
Applying chart zones and confluence areas to Royalty Pharma plcInsider Selling & Free Daily Entry Point Trade Alerts - newser.com
Quantitative breakdown of Royalty Pharma plc recent moveMarket Growth Report & Reliable Trade Execution Plans - newser.com
Is Royalty Pharma Plc's (NASDAQ:RPRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - 富途牛牛
Royalty Pharma: Guidance Raised Again, Platform Strength Intact -- Buy Reiterated (NASDAQ:RPRX) - Seeking Alpha
Why retail investors pile into Royalty Pharma plc stockWeekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Is Royalty Pharma plc (RPD) stock a buy during volatile marketsVolume Spike & Verified Chart Pattern Signals - newser.com
Monetta Financial Services Inc. Acquires New Shares in Royalty Pharma PLC $RPRX - MarketBeat
What drives Royalty Pharma plc stock priceResistance Breakout Alerts & Accelerated Capital Growth - earlytimes.in
How Royalty Pharma plc (RPD) stock performs in easing cyclesEarnings Growth Report & Community Trade Idea Sharing - newser.com
Mitsubishi UFJ Trust & Banking Corp Lowers Position in Royalty Pharma PLC $RPRX - MarketBeat
Will Royalty Pharma plc (RPD) stock maintain strong growthRisk Management & Weekly High Return Stock Opportunities - newser.com
Jupiter Asset Management Ltd. Acquires 1,380,115 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance
Is Royalty Pharma plc reversing from oversold territoryWeekly Volume Report & Step-by-Step Swing Trade Plans - newser.com
Ex-Dividend Reminder: Royalty Pharma, Cencora and MMM - Nasdaq
Bank of New York Mellon Corp Lowers Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Purchased by Aviva PLC - MarketBeat
What MACD signals say about Royalty Pharma plc2025 Bull vs Bear & Comprehensive Market Scan Reports - newser.com
로열티 파마 (RPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.07%
1.20%
자본화:
|
볼륨(24시간):